Commerzbank Aktiengesellschaft FI Takes Position in Cigna Corporation (CI)

Commerzbank Aktiengesellschaft FI acquired a new position in shares of Cigna Corporation (NYSE:CI) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,395 shares of the health services provider’s stock, valued at approximately $261,000.

Other institutional investors also recently made changes to their positions in the company. Skandinaviska Enskilda Banken AB publ lifted its stake in Cigna by 6.3% in the third quarter. Skandinaviska Enskilda Banken AB publ now owns 45,255 shares of the health services provider’s stock valued at $8,460,000 after buying an additional 2,700 shares during the last quarter. KBC Group NV lifted its stake in Cigna by 45.9% in the third quarter. KBC Group NV now owns 140,037 shares of the health services provider’s stock valued at $26,178,000 after buying an additional 44,075 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Cigna by 3.6% in the third quarter. Dimensional Fund Advisors LP now owns 1,431,295 shares of the health services provider’s stock valued at $267,567,000 after buying an additional 49,879 shares during the last quarter. BB&T Securities LLC lifted its stake in Cigna by 1.9% in the third quarter. BB&T Securities LLC now owns 28,534 shares of the health services provider’s stock valued at $5,333,000 after buying an additional 532 shares during the last quarter. Finally, InterOcean Capital LLC purchased a new stake in Cigna in the third quarter valued at approximately $221,000. 87.85% of the stock is owned by institutional investors and hedge funds.

Several research firms have recently commented on CI. Zacks Investment Research cut Cigna from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Citigroup increased their price objective on Cigna from $198.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Morgan Stanley increased their price objective on Cigna from $195.00 to $223.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Jefferies Group increased their price objective on Cigna from $221.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $220.00 price objective (up previously from $185.00) on shares of Cigna in a research report on Friday, November 3rd. Three research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Cigna presently has an average rating of “Buy” and a consensus target price of $201.50.

Shares of Cigna Corporation (NYSE:CI) opened at $209.16 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. The company has a market capitalization of $51,768.04, a price-to-earnings ratio of 20.23, a P/E/G ratio of 1.60 and a beta of 0.50. Cigna Corporation has a 52 week low of $131.03 and a 52 week high of $212.46.

Cigna (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. Cigna had a return on equity of 18.85% and a net margin of 5.74%. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same quarter last year, the company earned $1.94 earnings per share. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. research analysts expect that Cigna Corporation will post 10.34 EPS for the current year.

In other news, EVP Alan Muney sold 15,345 shares of the firm’s stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the transaction, the executive vice president now directly owns 28,457 shares in the company, valued at approximately $5,714,165.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Christopher J. Hocevar sold 8,387 shares of the firm’s stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $200.32, for a total value of $1,680,083.84. Following the completion of the transaction, the insider now owns 12,363 shares in the company, valued at $2,476,556.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,956 shares of company stock worth $7,165,490. 1.30% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://ledgergazette.com/2017/12/12/commerzbank-aktiengesellschaft-fi-takes-position-in-cigna-corporation-ci.html.

Cigna Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply